BioVigilant™ is proud to be partnered with the following companies as sources of its continued growth.

Alerion Capital Group is a private equity and management advisory firm investing in later stage, mid-market businesses in the Mountain West.  Alerion’s investment philosophy focuses on companies that will benefit most from our experience and knowledge, centering around technology product and service providers. 

Companies we seek are typically interested in Alerion’s on-going management assistance, mentoring and guidance, in addition to the capital we provide.  This collaboration coupled with access to our significant network of expertise and talented management candidates enables companies to more effectively realize their potential and generate attractive returns. 

Alerion was founded by James Unruh, former Chairman and CEO Unisys, as a means of helping managers build their companies, leverage his 30+ years of technology industry experience, as well as benefit from his ongoing participation in corporate boards, including Prudential, Tenet Healthcare, and Qwest.  The Alerion team extends on this foundation bringing extensive experience from the technology and investment banking fields.  Alerion is headquartered in Scottsdale , Arizona and has a Salt Lake City office.  For more information go to www.alerion.com.

The Desert Angels are a Tucson based non-profit organization of accredited investors who seek opportunities to invest in regional startup or early stage no tech, low tech, or high tech companies. The organization itself serves only as a forum for its members who individually invest from their personal funds.  The Desert Angels encourages co-ventures with venture capital funds, other angel groups, and individual investors. For more information go to www.edesertangels.com.

Pearl Street Venture Funds invests in early staged life sciences companies primarily in the biotech, medical device, pharmaceutical and agri-bio sectors. The fund actively seeks therapeutic product companies, "best of breed" enabling technologies and technologies that add value to the Pharma industry. Pearl Street Venture Funds possesses significant life sciences industry experience, venture capital experience and success in advising early stage companies on growth and commercialization strategies, successful exits and syndicating venture deals. For more information visit www.psvf.com.